High-content screening identifies FDA-approved activators of mitophagy

Coverage, in order

1. 2d ago
   bioRxiv - Cell Biology obscure study

   High-content screening identifies FDA-approved activators of mitophagy

   Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.